Use of Hy's Law and a New Composite Algorithm to Predict Acute Liver Failure in Patients With Drug-Induced Liver Injury

被引:354
作者
Robles-Diaz, Mercedes [1 ,2 ]
Isabel Lucena, M. [1 ,2 ]
Kaplowitz, Neil [3 ]
Stephens, Camilla [1 ,2 ]
Medina-Caliz, Inmaculada [1 ,2 ]
Gonzalez-Jimenez, Andres [1 ]
Ulzurrun, Eugenia [1 ,2 ]
Gonzalez, Ana F. [1 ]
Fernandez, M. Carmen [4 ]
Romero-Gomez, Manuel [2 ,5 ]
Jimenez-Perez, Miguel [6 ]
Bruguera, Miguel [2 ,7 ]
Prieto, Martin [2 ,8 ]
Bessone, Fernando [9 ]
Hernandez, Nelia [10 ]
Arrese, Marco [11 ]
Andrade, Raul J. [1 ,2 ]
机构
[1] Univ Malaga, Unidad Gest Clin Enfermedades Digest, Serv Farmacol Clin, Inst Invest Biomed Malaga IBIMA,Hosp Univ Virgen, E-29071 Malaga, Spain
[2] Ctr Invest Biomed Red Enfermedades Hepat & Digest, Barcelona, Spain
[3] Univ So Calif, Keck Sch Med, Res Ctr Liver Dis, Los Angeles, CA 90033 USA
[4] Hosp Torrecardenas, Serv Farm, Almeria, Spain
[5] Hosp Univ Valme, Unidad Gest Clin Enfermedades Digest, Seville, Spain
[6] Hosp Reg Univ Carlos Haya, Inst Invest Biomed Malaga IBIMA, Unidad Gest Clin Enfermedades Digest, Malaga, Spain
[7] Hosp Clin Barcelona, Inst Enfermedades Digest & Metab, Barcelona, Spain
[8] Hosp La Fe, Unidad Gest Clin Enfermedades Digest, Valencia, Spain
[9] Univ Nacl Rosario, Hosp Prov Ctr, Fac Ciencias Med, Serv Gastroenterol & Hepatol, RA-2000 Rosario, Santa Fe, Argentina
[10] Univ Republica, Fac Med, Clin Gastroenterol, Hosp Clin, Montevideo, Uruguay
[11] Pontificia Univ Catolica Chile, Fac Med Pontificia, Dept Gastroenterol, Santiago, Chile
关键词
Idiosyncratic Hepatotoxicity; Prognostic Risk Factor; Prediction; Progression; HEPATIC-FAILURE; INDICATORS; NETWORK; SWEDEN;
D O I
10.1053/j.gastro.2014.03.050
中图分类号
R57 [消化系及腹部疾病];
学科分类号
100201 [内科学];
摘要
BACKGROUND & AIMS: Hy's Law, which states that hepatocellular drug-induced liver injury (DILI) with jaundice indicates a serious reaction, is used widely to determine risk for acute liver failure (ALF). We aimed to optimize the definition of Hy's Law and to develop a model for predicting ALF in patients with DILI. METHODS: We collected data from 771 patients with DILI (805 episodes) from the Spanish DILI registry, from April 1994 through August 2012. We analyzed data collected at DILI recognition and at the time of peak levels of alanine aminotransferase (ALT) and total bilirubin (TBL). RESULTS: Of the 771 patients with DILI, 32 developed ALF. Hepatocellular injury, female sex, high levels of TBL, and a high ratio of aspartate aminotransferase (AST):ALT were independent risk factors for ALF. We compared 3 ways to use Hy's Law to predict which patients would develop ALF; all included TBL greater than 2-fold the upper limit of normal (x ULN) and either ALT level greater than 3 x ULN, a ratio (R) value (ALT x ULN/alkaline phosphatase x ULN) of 5 or greater, or a new ratio (nR) value (ALT or AST, whichever produced the highest x ULN/alkaline phosphatase x ULN value) of 5 or greater. At recognition of DILI, the R- and nR-based models identified patients who developed ALF with 67% and 63% specificity, respectively, whereas use of only ALT level identified them with 44% specificity. However, the level of ALT and the nR model each identified patients who developed ALF with 90% sensitivity, whereas the R criteria identified them with 83% sensitivity. An equal number of patients who did and did not develop ALF had alkaline phosphatase levels greater than 2 x ULN. An algorithm based on AST level greater than 17.3 x ULN, TBL greater than 6.6 x ULN, and AST:ALT greater than 1.5 identified patients who developed ALF with 82% specificity and 80% sensitivity. CONCLUSIONS: When applied at DILI recognition, the nR criteria for Hy's Law provides the best balance of sensitivity and specificity whereas our new composite algorithm provides additional specificity in predicting the ultimate development of ALF.
引用
收藏
页码:109 / U204
页数:15
相关论文
共 32 条
[1]
Simvastatin Lowers Portal Pressure in Patients With Cirrhosis and Portal Hypertension: A Randomized Controlled Trial [J].
Abraldes, Juan G. ;
Albillos, Agustin ;
Banares, Rafael ;
Turnes, Juan ;
Gonzalez, Rosario ;
Garcia-Pagan, Juan Carlos ;
Bosch, Jaime .
GASTROENTEROLOGY, 2009, 136 (05) :1651-1658
[2]
Case Definition and Phenotype Standardization in Drug-Induced Liver Injury [J].
Aithal, G. P. ;
Watkins, P. B. ;
Andrade, R. J. ;
Larrey, D. ;
Molokhia, M. ;
Takikawa, H. ;
Hunt, C. M. ;
Wilke, R. A. ;
Avigan, M. ;
Kaplowitz, N. ;
Bjornsson, E. ;
Daly, A. K. .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2011, 89 (06) :806-815
[3]
Outcome of acute idiosyncratic drug-induced liver injury:: Long-term follow-up in a hepatotoxicity registry [J].
Andrade, Raul J. ;
Lucena, M. Isabel ;
Kaplowitz, Neil ;
Garcia-Munoz, Beatriz ;
Borraz, Yolanda ;
Pachkoria, Ketevan ;
Garcia-Cortes, Miren ;
Fernandez, M. Carmen ;
Pelaez, Gloria ;
Rodrigo, Luis ;
Duran, Jose A. ;
Costa, Joan ;
Planas, Ramon ;
Barriocanal, Anabel ;
Guarner, Carlos ;
Romero-Gomez, Manuel ;
Munoz-Yague, Teresa ;
Salmeron, Javier ;
Hidalgo, Ramon .
HEPATOLOGY, 2006, 44 (06) :1581-1588
[4]
Drug-induced liver injury:: An analysis of 461 incidences submitted to the Spanish Registry over a 10-year period [J].
Andrade, RJ ;
Lucena, MI ;
Fernández, MC ;
Pelaez, G ;
Pachkoria, K ;
García-Ruiz, E ;
García-Munoz, B ;
González-Grande, R ;
Pizarro, A ;
Durán, JA ;
Jiménez, M ;
Rodrigo, L ;
Romero-Gomez, M ;
Navarro, JM ;
Planas, R ;
Costa, J ;
Borras, A ;
Soler, A ;
Salmerón, J ;
Martin-Vivaldi, R .
GASTROENTEROLOGY, 2005, 129 (02) :512-521
[5]
[Anonymous], 2009, GUID IND DRUG IND LI
[6]
BENICHOU C, 1990, J HEPATOL, V11, P272
[7]
Acute liver failure [J].
Bernal, William ;
Auzinger, Georg ;
Dhawan, Anil ;
Wendon, Julia .
LANCET, 2010, 376 (9736) :190-201
[8]
Building a Spanish-Latin American network on drug induced liver injury: much to get from a joint collaborative initiative [J].
Bessone, Fernando ;
Hernandez, Nelia ;
Davalos, Milagros ;
Parana, Raymundo ;
Schinoni, Maria I. ;
Lizarzabal, Maribel ;
Kershenobich, David ;
Loaeza, Aurora ;
Arrese, Marco ;
Chirino, Ruby A. ;
Mendez-Sanchez, Nahum ;
Fay, Fabian ;
Bruguera, Miguel ;
Stephens, Camilla ;
Lucena, Maria I. ;
Andrade, Raul J. .
ANNALS OF HEPATOLOGY, 2012, 11 (04) :544-549
[9]
Outcome and prognostic markers in severe drug-induced liver disease [J].
Björnsson, E ;
Olsson, R .
HEPATOLOGY, 2005, 42 (02) :481-489
[10]
Severe jaundice in Sweden in the new millennium:: Causes, investigations, treatment and prognosis [J].
Björnsson, E ;
Ismael, S ;
Nejdet, S ;
Kilander, A .
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2003, 38 (01) :86-94